Core Laboratories

Core Laboratories EBITDA Margin

The EBITDA Margin of Core Laboratories (CLB) as of Nov 22, 2026 is 12.37 %. In the previous year, EBITDA Margin was 14.03 % — a change of -11.84% (lower).

EBITDA Margin

12.37 %

YoY

-11.84%

Last updated:

EBITDA Margin of Core Laboratories is 2025 12.37 % . EBITDA Margin of Core Laboratories was 2024 14.03 % . It decreases by -11.84% lower compared to the previous year.

The Core Laboratories EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
20.22 USD
Jan 1, 2019
17.85 USD
Jan 1, 2020
-11.47 USD
Jan 1, 2021
13.56 USD
Jan 1, 2022
11.99 USD
Jan 1, 2023
13.81 USD
Jan 1, 2024
14.03 USD
Jan 1, 2025
12.37 USD
The Core Laboratories EBITDA Margin history
YEAREBITDA MarginYoY
12.37 %-11.84%
14.03 %+1.58%
13.81 %+15.21%
11.99 %-11.57%
13.56 %-218.18%
-11.47 %-164.27%
17.85 %-11.72%
20.22 %-2.57%
20.75 %+9.74%
18.91 %-20.01%
23.64 %-31.25%
34.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Core Laboratories Stock analysis

What does Core Laboratories do? Core Laboratories NV generates revenue through its three business segments: Reservoir Description, Production Enhancement, and Reservoir Management. The Reservoir Description segment offers proprietary and patented services for characterizing petroleum reservoir rock, fluid, and gas samples, providing analytical and field services to the oil and gas industry. The Production Enhancement segment delivers products and services related to well completions, perforations, stimulations, and production, including integrated diagnostic services to assess well completion effectiveness. The Reservoir Management segment integrates data from the other two segments to optimize oil and gas recovery for clients. The company serves the oil and gas industry, with clients primarily seeking enhanced reservoir characterization, production optimization, and management solutions. Core Laboratories NV's services are tailored to improve production efficiency and recovery rates, targeting operators and exploration firms within the energy sector. Revenue is derived from contracts for these specialized services across all three segments. The firm operates with a workforce of 4,300 full-time employees, delivering these services globally. Its proprietary and patented technologies differentiate its offerings, ensuring clients receive tailored solutions for reservoir management and production enhancement. The company's revenue model relies on long-term contracts and service-based engagements rather than product sales. Core Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Core Laboratories stock

EBITDA Margin of Core Laboratories is 12.37 % in 2025.

EBITDA Margin of Core Laboratories changed from 14.03 % to 12.37 %, representing a -11.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Core Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Core Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Core Laboratories

All Key Metrics — Core Laboratories